0001209191-17-009533.txt : 20170210
0001209191-17-009533.hdr.sgml : 20170210
20170210161211
ACCESSION NUMBER: 0001209191-17-009533
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170209
FILED AS OF DATE: 20170210
DATE AS OF CHANGE: 20170210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atara Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001604464
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 460920988
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BLVD
STREET 2: SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-278-8930
MAIL ADDRESS:
STREET 1: 611 GATEWAY BLVD
STREET 2: SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Turner Heather D
CENTRAL INDEX KEY: 0001403571
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36548
FILM NUMBER: 17593422
MAIL ADDRESS:
STREET 1: 12481 HIGH BLUFF DRIVE, SUITE 160
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-02-09
0
0001604464
Atara Biotherapeutics, Inc.
ATRA
0001403571
Turner Heather D
C/O ATARA BIOTHERAPEUTICS, INC.
611 GATEWAY BOULEVARD, SUITE 900
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
EVP, General Counsel & Sec.
Common Stock
2017-02-09
4
S
0
11582
15.70
D
86775
D
Common Stock
2017-02-09
4
S
0
633
16.16
D
86142
D
Transaction pursuant to Rule 10b5-1 Plan adopted September 23, 2016.
The price in Column 4 is a weighted average sale price. The prices actually received ranged from $15.15 to $16.10. The reporting person will provide to the
issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price in Column 4 is a weighted average sale price. The prices actually received ranged from $16.15 to $16.20. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
/s/ Tina Gullotta, Attorney-in-Fact for Heather D. Turner
2017-02-10